Partial Lipodystrophy: Clinical Trials

1 trial for Partial Lipodystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Partial Lipodystrophy: new trials by email Literature Review of Partial Lipodystrophy trials Research Report on Partial Lipodystrophy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Pegvisomant - Insulin Receptor Mutation, Partial Lipodystrophy
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)252023-01-232026-08-18

Narrower conditions

Insulin Resistance (1)  ·  Lipodystrophy, Partial, Acquired (1)

Broader conditions

Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

pegvisomant (1)

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

United States (1)

Top investigators

Rebecca J Brown, M.D. (1)